A 12-Year Low and a Boardroom Bet: Why Nike Insiders Are Buying Into the Storm

Nike shares hit 10-year low despite insider purchases; Wells Fargo downgrades on GLP-1 shifts. Revenue flat, China warning, but management buys 64K shares.

Nike shares have cratered to levels not seen in more than a decade, closing Friday at €36.02 — the bottom of a 52-week range that has wiped out roughly 75% of the stock’s value since its 2021 peak. The year-to-date decline stands at 33%, and the pain is far from over, with structural headwinds piling up faster than the company can pivot. Yet inside the boardroom, a different story is unfolding: director Timothy Cook just scooped up 25,000 shares at an average price of $42.43, adding to a flurry of insider buying that has seen management acquire roughly 64,000 shares over the past 90 days.

The GLP-1 Wildcard That Has Wells Fargo Backing Away

The most unexpected weight on Nike’s outlook comes from an unlikely source: the booming market for GLP-1 weight-loss drugs. Wells Fargo slashed its rating to Equal Weight from Overweight and cut its price target to $45 from $55, citing a shift in consumer spending patterns. According to the bank, patients shedding pounds on these medications are buying more clothing overall, but sportswear and activewear are lagging behind general apparel as shoppers with new body shapes gravitate toward everyday fashion rather than performance gear. Nike, as the dominant player in athletic footwear and activewear, stands to miss much of the potential GLP-1-driven retail uplift.

That downgrade follows a modest upgrade from Wall Street Zen on May 16, which lifted the stock from Sell to Hold — a call that landed almost exactly at the current trough. The consensus among analysts now leans toward Hold, with an average price target still well above the trading level, but the gap between bulls and bears is widening.

Earnings: A Miss in All but the Headlines

The third fiscal quarter painted a mixed picture. Nike posted earnings per share of $0.35, beating expectations by $0.06, but revenue of $11.28 billion was virtually flat year-over-year. Net income slumped to $520 million, a 35% decline on a per-share basis, as tariff-related costs hammered gross margins. Management has warned of further deterioration in the current quarter, with the China market singled out for a potential revenue drop of roughly one-fifth, driven by local disruptions and market saturation.

Despite the earnings beat on the bottom line, the stock remains trapped near its lows. The price-to-earnings ratio of roughly 27 still commands a premium over the sector average of about 21, suggesting that while the shares have been crushed, they are not bargain-bin cheap by historical standards.

Insider and Institutional Conviction

The insider buying is not limited to Cook. Combined purchases by management over the past 90 days total roughly 64,000 shares, a clear vote of confidence at these levels. On the institutional side, Phoenix Financial Ltd. has boosted its stake by 42% over the same period, now holding around 125,000 shares worth nearly $8 million.

Those moves stand in stark contrast to the broader market sentiment. The stock is trading 33% below its 200-day moving average, and the macroeconomic backdrop is hardly supportive: rising bond yields and an oil price above $100 have reignited inflation fears, weighing on consumer discretionary names across the board.

Structural Bleeding and a Dividend Lifeline

Nike’s retreat from wholesale distribution in favor of a direct-to-consumer push has cost it market share, allowing nimble competitors to fill the gaps. The company holds $8.1 billion in cash — enough to fund a strategic reset — but the path to a turnaround remains unclear. The ongoing strategy correction has yet to show up in revenue or market share data.

One bright spot: the dividend. Nike has raised its payout for 24 consecutive years, and at current levels the quarterly distribution of $0.41 per share yields nearly 4%. That provides a floor for income-focused investors, but it will take more than a reliable check to reverse the slide. The next quarterly report will be the critical test, when management must quantify the exact damage in China and lay out a credible plan to reclaim lost ground.